These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 304802)

  • 21. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
    Kirchner H; Glaser M; Herberman R
    Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
    [No Abstract]   [Full Text] [Related]  

  • 22. The activation of macrophages by Corynebacterium parvum: effect of anti-complementary agents cobra venom factor and sodium cyanate.
    Ghaffar A
    J Reticuloendothel Soc; 1980 Mar; 27(3):327-35. PubMed ID: 7365736
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of Corynebacterium parvum on T cell dependent tumor regression.
    McBride WH; Peters LJ; Mason KA; Barrow G
    J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice.
    Kirchner H; Chmielarczyk W; Storch E; Schindler L
    Behring Inst Mitt; 1984 May; (74):183-8. PubMed ID: 6206840
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pleural effusion. Local treatment by Corynebacterium parvum].
    Serrou B; Cupissol D
    Nouv Presse Med; 1980 Jun; 9(25):1777-8. PubMed ID: 7383874
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
    Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
    J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of nonspecific immune stimulation with Corynebacterium parvum and polidin on the Ehrlich ascites tumor growth.
    Todoruţiu C; Rişcă R; Daicoviciu D; Mulea R
    Morphol Embryol (Bucur); 1982; 28(1):77-83. PubMed ID: 6461826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
    Storch E; Baumgartl D; Kirchner H
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Corynebacterium parvum on the course of a Listeria monocytogenes infection in normal and congenitally athymic (nude) mice.
    Ruittenberg EJ; van Noorle Jansen LM
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):197-205. PubMed ID: 808049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Corynebacterium parvum on cellular and humoral antitumoral immune effector mechanisms.
    Mantovani A; Tagliabue A; Vecchi A; Spreafico F
    Eur J Cancer (1965); 1976 Feb; 12(2):113-23. PubMed ID: 1083341
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppression of marrow B lymphocytes by administration of Corynebacterium parvum in mice.
    Jyonouchi H; Kincade PW; Good RA
    J Immunol; 1981 Dec; 127(6):2502-7. PubMed ID: 6457877
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of resistance to Listeria monocytogenes enhanced by Corynebacterium parvum in mice.
    Miyata H; Nomoto K; Takeya K
    Immunology; 1980 May; 40(1):33-9. PubMed ID: 6968291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvanticity of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and Corynebacterium parvum with respect to host immune response to coccidial antigens.
    Lillehoj HS; Lindblad EB; Nichols M
    Avian Dis; 1993; 37(3):731-40. PubMed ID: 8257364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy of cancer with corynebacterium parvum.
    Halpern B
    Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible mechanisms in the anti-tumour activity of C. parvum.
    Cullen RT
    Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active immunization of rats against two tumoral ascites using live cells associated with Corynebacterium parvum.
    Lupu A
    Arch Roum Pathol Exp Microbiol; 1987; 46(2):167-71. PubMed ID: 3455654
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.